Implementation of LabVantage LIMS at Oxford Biomedica

This technical report outlines the implementation of the LabVantage Laboratory Information Management System (LIMS) at Oxford Biomedica, a Contract Development and Manufacturing Organization (CDMO) based in the UK. The report details the company's decision to adopt a LIMS to enhance operational efficiency in response to the growing demand for cell and gene therapies. It describes the challenges faced with a paper-based system and the need for automation in sample management, metrics tracking, and data integrity. The report explains the selection process for LabVantage as a partner, highlighting key capabilities such as sample management, instrument integration, and automated Certificate of Analysis generation. It also discusses the advantages of a Software-as-a-Service (SaaS) model, including cost-effectiveness and ease of implementation. The anticipated go-live date for the LIMS is set for the end of Q2 2024, marking a significant step towards streamlining viral vector development and manufacturing processes.